Case Study: Telemedicine Provider, Psychiatry UK’s Real-World Experience using PREDICTIX Genetics
The PREDICTIX Genetics tool was used to help personalize treatment for some of PUK’s most challenging patients, mainly those that had been treatment resistant or were first-time patients.
The results showed:
- 71.4% of patients that used the PREDICTIX Genetics-guided treatment recommendation responded to their first antidepressant prescribed.
- This was nearly double the prescribing success rate compared to unguided treatment selection, where only 40% responded to their first antidepressant prescribed.